Completed PHASE2 INTERVENTIONAL 2-arm NCT03951025

Study of the Bioavailability of a Food Supplement Rich in Melatonin Administered Sublingually and Orally (MELATONIN) (MELATONIN)

Study of the Bioavailability of a Food Supplement Rich in Melatonin Administered Sublingually Compared to Its Oral Administration. Randomized, Crossover, Single-blind Study

Sponsor: Fundació Eurecat

Conditions Biological Availability

Interventions Melatonin oral administration Melatonin sublingual administration

Updated 6 times since 2019 Last updated: Feb 25, 2022 Started: Jun 5, 2019 Primary completion: Aug 7, 2019 Completion: Aug 7, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Biological Availability, this trial is completed. The trial is conducted by Fundació Eurecat and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Mar 2022 — Jul 2024 [monthly]

Completed PHASE2

Status: Unknown Status → Completed
Oct 2021 — Mar 2022 [monthly]

Unknown Status PHASE2

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Not Yet Recruiting PHASE2

▶ Show 1 earlier version

Jun 2019 — Jan 2021 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundació Eurecat
Hospital Universitari Sant Joan de Reus
Plantas Medicinales y Complementos Alimenticios (PLAMECA), S.A.
Technological Centre of Nutrition and Health, Spain
University Rovira i Virgili

Data source: Technological Centre of Nutrition and Health, Spain

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Reus, Spain